Absence of chromosome 17 polysomy in breast cancer: analysis by CEP17 chromogenic in situ hybridization and multiplex ligation-dependent probe amplification Cathy B. MoelansRoel A. de WegerPaul J. van Diest Editorial 18 September 2009 Pages: 1 - 7
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature Jetske RuiterkampAdri C. VoogdMiranda F. Ernst Review 13 December 2009 Pages: 9 - 16
Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications Xuefen Le BourhisRodrigue RomonHubert Hondermarck Review 24 December 2009 Pages: 17 - 24
Evaluation of malignancy-risk gene signature in breast cancer patients Dung-Tsa ChenAejaz NasirTimothy Yeatman Preclinical Study 22 March 2009 Pages: 25 - 34
Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression Jiaqi FuAmy M. WeiseMelissa Runge-Morris Preclinical Study 24 March 2009 Pages: 35 - 45
Both t-Darpp and DARPP-32 can cause resistance to trastuzumab in breast cancer cells and are frequently expressed in primary breast cancers Sophie HamelAmélie BouchardMark Basik Preclinical Study 20 March 2009 Pages: 47 - 57
Effects of autotransplanted lymph node fragments on the lymphatic system in the pig model K. S. BlumC. HadamitzkyR. Pabst Preclinical study 20 March 2009 Pages: 59 - 66
Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas Friedrich OtterbachRainer CalliesAgnes Bankfalvi Preclinical study 21 March 2009 Pages: 67 - 76
Abnormal muscles that may affect axillary lymphadenectomy: surgical anatomy K. NatsisK. VlasisJ. Koebke Preclinical study 21 March 2009 Pages: 77 - 82
A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks L. J. LancashireD. G. PoweG. R. Ball Preclinical study 04 April 2009 Pages: 83 - 93
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification Pamela KlingbeilRachael NatrajanClare M. Isacke Preclinical study 07 April 2009 Pages: 95 - 109
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer Alejandra T. PerezBanu ArunCharles L. Shapiro Clinical trial 07 January 2010 Pages: 111 - 118
Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature Youlia M. KirovaAlexia SavignoniAlain Fourquet Clinical Trial 24 December 2009 Pages: 119 - 126
Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study Karine BriotMichèle Tubiana-HulinChristian Roux Clinical trial 25 December 2009 Pages: 127 - 134
Pre-operative assessment enables early diagnosis and recovery of shoulder function in patients with breast cancer Barbara A. SpringerEllen LevyJerome Danoff Clinical trial 07 January 2010 Pages: 135 - 147
Urban–rural differences in breast cancer incidence by hormone receptor status across 6 years in Egypt Subhojit DeyAmr S. SolimanSofia D. Merajver Epidemiology 23 June 2009 Pages: 149 - 160
Breast cancer hormone receptor status in Egypt: are we asking the questions that matter most? Benjamin O. Anderson Invited commentary 18 July 2009 Pages: 161 - 163
Mutation screening of the MERIT40 gene encoding a novel BRCA1 and RAP80 interacting protein in breast cancer families Szilvia SolyomJeffery Patterson-FortinRobert Winqvist Epidemiology 02 July 2009 Pages: 165 - 168
No evidence that social stress is associated with breast cancer incidence Paul G. SurteesNicholas W. J. WainwrightSheila A. Bingham Epidemiology 02 July 2009 Pages: 169 - 174
Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study Jane C. FigueiredoRobert W. HaileJonine L. Bernstein Epidemiology 14 July 2009 Pages: 175 - 183
Impact of obesity on diagnosis and treatment of breast cancer Carole DegliseChristine BouchardyHelena Marieke Verkooijen Epidemiology 14 July 2009 Pages: 185 - 193
Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province Zhenkun FuDalin LiDianjun Li Epidemiology 08 July 2009 Pages: 195 - 202
Low level alcohol intake, cigarette smoking and risk of breast cancer in Asian-American women Linda Morris BrownGloria GridleyRegina G. Ziegler Epidemiology 12 July 2009 Pages: 203 - 210
Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis Konstantinos P. EconomopoulosTheodoros N. Sergentanis Epidemiology 10 July 2009 Pages: 211 - 216
Tumor marker phenotype concordance in second primary breast cancer, California, 1999–2004 Monica BrownKatrina BauerMary Pare Epidemiology 21 July 2009 Pages: 217 - 227
Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis Theodoros N. SergentanisKonstantinos P. Economopoulos Epidemiology 24 July 2009 Pages: 229 - 234
Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers Anouk PijpePeggy MandersMatti A. Rookus Epidemiology 13 August 2009 Pages: 235 - 244
Incidence of chemotherapy-induced amenorrhea in hormone-sensitive breast cancer patients: the impact of addition of taxanes to anthracycline-based regimens José Alejandro Pérez-FidalgoSusana RosellóAna Lluch Brief Report 03 July 2009 Pages: 245 - 251
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo Ramon C. SunMitali FadiaAnneke C. Blackburn Brief Report 19 June 2009 Pages: 253 - 260
Eligible and not eligible studies in the recent meta-analysis about p53 polymorphism and breast cancer risk Theodoros N. SergentanisKonstantinos P. Economopoulos Letter to the editor 17 September 2009 Pages: 261 - 262
Additive effects of genetic variations of xenobiotic detoxification enzymes and DNA repair gene XRCC1 on the susceptibility to breast cancer Mohammad MasoudiIraj SaadatMostafa Saadat Letter to the editor 03 September 2009 Pages: 263 - 265
A novel germline CHEK2 deletion truncating the kinase domain identified in a French family with high-risk of breast/ovarian cancer Pauline EscudieSylvia Monteil-OntenienteChristine Toulas Letter to the editor 19 September 2009 Pages: 267 - 270
Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China A-Yong CaoZhen HuZhi-Ming Shao Letter to the Editor 24 October 2009 Pages: 271 - 272